Filter Results:
(2,858)
Show Results For
- All HBS Web
(2,858)
- People (11)
- News (800)
- Research (1,626)
- Events (4)
- Multimedia (35)
- Faculty Publications (1,010)
Show Results For
- All HBS Web
(2,858)
- People (11)
- News (800)
- Research (1,626)
- Events (4)
- Multimedia (35)
- Faculty Publications (1,010)
- 23 Jun 2023
- HBS Case
This Company Lets Employees Take Charge—Even with Life and Death Decisions
care teams after experiencing firsthand as a nurse, and then a decade as a senior leader of two large health care organizations, how the health care system managed quality and productivity in ways that... View Details
- January 2009 (Revised May 2011)
- Case
China Mobile's Rural Communications Strategy
By: William C. Kirby, F. Warren McFarlan, G.A. Donovan and Tracy Manty
China Mobile was the world's leading mobile communications service provider with over 400 million customers. In some cities, its penetration rate was over 100%. With such huge successes, Chairman Wang Jianzhou was exploring ways to expand its customer base. Nearly... View Details
Keywords: Communication Technology; Mobile and Wireless Technology; Investment; Rural Scope; Strategy; Growth and Development Strategy; Corporate Social Responsibility and Impact; Business and Government Relations; Telecommunications Industry; China
Kirby, William C., F. Warren McFarlan, G.A. Donovan, and Tracy Manty. "China Mobile's Rural Communications Strategy." Harvard Business School Case 309-034, January 2009. (Revised May 2011.)
- 09 Mar 2009
- Research & Ideas
How to Revive Health-Care Innovation
fundamental question: How do we make health care affordable? Most disruptions have three enablers: a simplifying technology, a business model innovation, and a disruptive value network. The technological... View Details
- October 1998 (Revised December 1999)
- Case
Gene Research, the Mapping of Life and the Global Economy
By: Ray A. Goldberg and Juan Enriquez-Cabot
A new firm is being created to speed up the process of mapping humans, animals, and plants by combining gene technology with rapid gene identification to improve the health and well being of the human population and the productivity of crops and animals. How does one... View Details
Keywords: Information Technology; Organizational Structure; Technological Innovation; Business Processes; Health Care and Treatment; Performance Productivity; Welfare; Agribusiness; Genetics; Science-Based Business; Biotechnology Industry; Agriculture and Agribusiness Industry
Goldberg, Ray A., and Juan Enriquez-Cabot. "Gene Research, the Mapping of Life and the Global Economy." Harvard Business School Case 599-016, October 1998. (Revised December 1999.)
- June 1999 (Revised May 2000)
- Case
EndoSonics
EndoSonics is a manufacturer of a sophisticated medical device--a catheter that can take ultrasonic images within the blood vessels of the heart. The company deals with a series of challenges that relate to implementing a difficult technology in the face of a complex... View Details
Keywords: Information Technology; Distribution; Decision Choices and Conditions; Corporate Strategy; Entrepreneurship; Health Care and Treatment; Problems and Challenges; Manufacturing Industry; Medical Devices and Supplies Industry
Roberts, Michael J., and Diana S. Gardner. "EndoSonics." Harvard Business School Case 899-262, June 1999. (Revised May 2000.)
- February 2022 (Revised February 2024)
- Case
Sekisui House and the In-Home Early Detection Platform
By: John D. Macomber and Akiko Kanno
To address an aging population and sales declines, a major Japanese homebuilder considers pivoting to provide and support an in-home health detection platform, in competition with tech companies. This case considers the point of view of major builders regarding how... View Details
Keywords: Voice Assistants; Architecture; Smart Home; Aging Society; Digitalization; Real Estate; Home Automation; Sensors; Strategy; Digital Platforms; Health Care and Treatment; Housing; Age; Health Industry; Health Industry; Health Industry; Japan
Macomber, John D., and Akiko Kanno. "Sekisui House and the In-Home Early Detection Platform." Harvard Business School Case 222-070, February 2022. (Revised February 2024.)
- December 2022 (Revised August 2023)
- Case
Circles.Life at a Crossroads of Growth
By: Juan Alcácer and Adina Wong
In June 2022, the founders of Singapore mobile operator Circles.Life had a crucial decision to make. Circles.Life developed a new business model in mobile telecommunications—a digital telco—built around its proprietary operating system. After expanding its brand in... View Details
Keywords: Business Model; Decisions; Technological Innovation; Applications and Software; Business Strategy; Telecommunications Industry; Singapore
Alcácer, Juan, and Adina Wong. "Circles.Life at a Crossroads of Growth." Harvard Business School Case 723-404, December 2022. (Revised August 2023.)
- Article
One Obstacle to Curing Cancer: Patient Data Isn't Shared
By: Richard G. Hamermesh and Kathy Giusti
Precision Medicine requires large datasets to identify the mutations that lead to various cancers. Currently, genomic information is hoarded in fragmented silos within numerous academic medical centers, pharmaceutical companies, and some disease-based foundations. For... View Details
Keywords: Healthcare; Technological And Scientific Innovation; Cancer Care In The U.S.; Cancer Treatment; Precision Medicine; Personalized Medicine; Data Sharing; Technological Innovation; Analytics and Data Science; Health Disorders; Medical Specialties; Research and Development; Customization and Personalization; Health Industry; United States
Hamermesh, Richard G., and Kathy Giusti. "One Obstacle to Curing Cancer: Patient Data Isn't Shared." Harvard Business Review (website) (November 28, 2016).
- 10 Feb 2023
- Research & Ideas
COVID-19 Lessons: Social Media Can Nudge More People to Get Vaccinated
Public health officials who took to social media to push people to get the COVID-19 vaccine may have wondered if they were screaming into a void. Over the course of the pandemic, health agencies around the... View Details
- 01 Jun 2017
- News
Building India’s First $100 Billion Company
- March 2015 (Revised September 2016)
- Technical Note
Baidu, Alibaba, and Tencent: The Three Kingdoms of the Chinese Internet
By: Feng Zhu and Aaron Smith
This note provides an overview of the Chinese Internet by describing its leading three companies: Baidu, Alibaba, and Tencent (BAT). While BAT had previously focused their respective businesses on distinct sectors of the online economy—Baidu for search, Alibaba for... View Details
Zhu, Feng, and Aaron Smith. "Baidu, Alibaba, and Tencent: The Three Kingdoms of the Chinese Internet." Harvard Business School Technical Note 615-039, March 2015. (Revised September 2016.)
- November 2023 (Revised April 2024)
- Case
Paytm: A Payments Journey in India
By: Álvaro Rodríguez Arregui, Amram Migdal and Kanika Jain
Paytm was an Indian financial technology company. Since its launch in 2010, it had built a dominant payments system in India, comprising mobile wallets, offline payments via QR codes, and a payments bank that offered no-frills banking. However, in 2016, the Indian... View Details
Keywords: Entrepreneurship; Situation or Environment; Business Ventures; Business Model; Banks and Banking; Business Strategy; Competition; Technology Industry; Technology Industry; Technology Industry; Asia; South Asia; India
Rodríguez Arregui, Álvaro, Amram Migdal, and Kanika Jain. "Paytm: A Payments Journey in India." Harvard Business School Case 824-039, November 2023. (Revised April 2024.)
- 21 Jul 2015
- Working Paper Summaries
Enabling Versus Controlling
Keywords: by Andrei Hagiu & Julian Wright
- 06 Jun 2018
- Video
David Mou, Blavatnik Fellow 2018-2019
- January 2020
- Case
Celata Bioinnovations
By: John R. Wells and Benjamin Weinstock
In December 2019, Jon Hu (HBS ‘19) and Dr. Samantha Dale Strasser, co-founders of Celata Bioinnovations, were raising $1 million to launch their company. They had founded Celata less than six months earlier with the aim of redefining the drug discovery process.... View Details
Keywords: Drug Development; Drug Discovery; Drug Trials; Pharmaceutical Companies; Pharmaceutical Company; Pharmaceuticals; Therapeutics; Biologics; Biotech; Biotechnology; Biopharmacy Company; Biochemistry; Technology Commercialization; Technology Companies; Drug Testing; Startup; Start-up; Startups; Start-ups; Startup Financing; Strategic Decision Making; Strategic Decisions; Strategic Evolution; FDA; Food And Drug Administration; Clinical Trials; Disease Management; Market Attractiveness; Market Entry; Market Opportunities; Health Disorders; Technological Innovation; Information Technology; Commercialization; Business Startups; Finance; Decision Making; Strategy; Market Entry and Exit; Opportunities; Pharmaceutical Industry; Biotechnology Industry
Wells, John R., and Benjamin Weinstock. "Celata Bioinnovations." Harvard Business School Case 720-427, January 2020.
- October 2021
- Case
(180) Days of Quibi
By: David J. Collis and Terrence Shu
Mobile streaming app Quibi was ready to take the entertainment world by storm at its April 2020 launch. Backed by $1.75 billion, influential investors from Hollywood to Wall Street eagerly anticipated early success for this brainchild of Meg Whitman, former CEO of... View Details
Collis, David J., and Terrence Shu. "(180) Days of Quibi." Harvard Business School Case 722-377, October 2021.
- 30 May 2024
- Research & Ideas
Racial Bias Might Be Infecting Patient Portals. Can AI Help?
registered nurses. The statistical evidence suggests that medical teams tended to prioritize messages from white patients, says Ariel Stern, a visiting professor at Harvard Business School and one of the study’s authors. As mobile... View Details
- 29 Apr 2019
- Research & Ideas
Is the Digital Age Making Us Petty?
With the rise of mobile payment apps like Venmo, many people can easily record the exact charges incurred by a lunch partner and pay back debts to the cent. They see themselves as efficient and fair. Others often have a different word for... View Details
Keywords: by Kristen Senz
- June 2012
- Case
GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships
By: Arthur A. Daemmrich and Ian McKown Cornell
Three years into a major public-private partnership between GlaxoSmithKline and Fiocuz, Brazil's principal health institute, the company assesses technology transfer and joint research under the agreement. GSK was selling its Synflorix vaccine (against pediatric... View Details
Keywords: Public-Private Partnerships; Business and Government Relations; Foreign Direct Investment; Health Care and Treatment; Globalized Firms and Management; Biotechnology Industry; Pharmaceutical Industry; Brazil
Daemmrich, Arthur A., and Ian McKown Cornell. "GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships." Harvard Business School Case 712-049, June 2012.
Satish K. Tadikonda
Satish Tadikonda is a Senior Lecturer in the Entrepreneurial Management Unit at Harvard Business School. In the MBA program, Satish teaches The Entrepreneurial Manager, a required first-year MBA course, and Entrepreneurship in Life Sciences, an elective course for... View Details